Since c-FLIPL inhibits the death receptor-mediated apoptotic pathway, we checked whether the reduction of c-FLIPL expression by miR-708 could increase sensitivity to drugs that induce death receptor-mediated apoptosis in renal cancer cell lines. Here, CFLAR is linked to renal carcinoma.